Park West Asset Management’s The Oncology Institute Warrant TOIIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-62,200
Closed -$43K 108
2021
Q4
$43K Hold
62,200
﹤0.01% 147
2021
Q3
$87K Hold
62,200
﹤0.01% 158
2021
Q2
$108K Hold
62,200
﹤0.01% 171
2021
Q1
$84K Buy
+62,200
New +$115K ﹤0.01% 171

Other funds holding TOIIW

Park West Asset Management's TOIIW Position: Q1 2022 in Review

Park West Asset Management sold out of The Oncology Institute Warrant (TOIIW) in Q1 2022, closing a stake of 62,200 shares — an estimated $43K sold.

Park West Asset Management first reported a position in TOIIW in Q1 2021 and held it in 4 quarters. The position peaked at $108K in Q2 2021. 12 funds tracked by Wall St. Rank hold TOIIW as of Q1 2022.

  • Park West Asset Management reported no remaining The Oncology Institute Warrant position as of Q1 2022 after selling out during the quarter.
  • Park West Asset Management sold 62,200 The Oncology Institute Warrant shares in Q1 2022, an estimated $43K.
  • Park West Asset Management first reported a position in The Oncology Institute Warrant in Q1 2021 and held it in 4 quarters.
  • Park West Asset Management's The Oncology Institute Warrant position peaked at $108K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held The Oncology Institute Warrant as of Q1 2022.

Based on Park West Asset Management's 13F filing for Q1 2022, filed 16 May 2022.